Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
This page is not indexed by search engines while we improve data quality.
Delenex Therapeutics Ag — Human Necessities
Delenex Therapeutics Ag holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Delenex Therapeutics Ag |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking Delenex Therapeutics Ag to Human Necessities.
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Recent filings
Latest patents from Delenex Therapeutics Ag in Human Necessities.
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Humanized antibodies against the beta-amyloid peptide
US-9273126-B2 · Mar 1, 2016 · US
Related pages
Navigate to parent entity pages.